FOXO (foxotechnologies.com) סך נכסי החברה

FOXO Technologies (FOXO) acts as a technological visionary in preventive healthcare, developing biological age assessment tools via DNA analysis. The business relies on unique AI algorithms for insurance underwriting, navigating strict genetic data protection regulations. The asset's market value dynamics, which reached 0.00, demonstrate a company in a model transition phase, where growth is supported by external capital in the absence of internal cash flow.

For the micro-cap biotech FOXO Technologies (FOXO), the total resource value, calculated reverse-engineered through return on assets (ROA), determines the scale of the base for commercializing epigenetic tests and AI platforms. By analyzing changes in controlled resources, an investor can see the balance between capital and liabilities, where asset growth confirms financial stability but necessitates efficient monetization of wellness services to prevent a decline in profitability.